Evaluator 12 |top| — Ep
In studies comparing different immunoassays (e.g., C-peptide assays), EP Evaluator 12 allows for the analysis of method performance near the detection limit.
Ensures all validation studies meet the stringent requirements of regulatory agencies (CAP/CLIA), reducing the risk of audit findings.
Performing a 5-day precision study (EP15-A3) used to be a manual headache.
EP Evaluator 12 provides advanced, industry-standard regression analysis, including: ep evaluator 12
EP Evaluator 12 is here — streamline your EP lab workflow with standardized procedure documentation, automated metrics, and robust reporting. Designed for electrophysiologists and EP teams, EP Evaluator 12 helps reduce documentation variability, speed charting, and improve outcomes tracking. Contact your rep to learn about customization and integration options.
: This module is a major leap forward, developed based on the latest CLSI EP9-A3 document. Unlike previous versions, it now supports up to five replicate tests per specimen (up from two), significantly improving precision levels and making it easier to identify and exclude outliers.
: Streamline instrument comparisons by processing multiple study calculations at once. In studies comparing different immunoassays (e
Version 12 improved the data entry process for these, allowing for faster imports and more graceful handling of incorrectly formatted data. Data Innovations Pro-Tips for Generating Better Reports EP Evaluator Overview | Data Innovations
Consider a 55-year-old with narrow complex tachycardia, 180 bpm. During the EP study, the real-time recording showed a VA interval of 70 ms—suggestive of typical AVNRT. However, the physician was uncertain due to odd retrograde atrial activation. Later, using EP Evaluator 12, the team reviewed the case with variable speed and filtering. They discovered a subtle eccentric atrial activation (CS 9,10 earlier than CS 1,2) that was missed live. This changed the diagnosis to septal accessory pathway mediated AVRT. The patient underwent successful ablation in a second procedure. Without EP Evaluator 12’s offline analysis, the diagnosis would have remained incorrect.
It helps laboratories monitor long-term imprecision and bias. Why Choose EP Evaluator 12? : This module is a major leap forward,
Version 12 prioritizes user experience with enhanced compatibility for Microsoft Edge and Windows 10/11. New desktop quick-help buttons guide users through statistical modules, while a new networking path log aids IT troubleshooting. Additionally, remote virtual training options allow the lab team to learn the software from their own desks.
: The most significant technical upgrade is the inclusion of the EP9 A3 module , built on the latest CLSI (Clinical & Laboratory Standards Institute) guidelines.
Recommended for comparing two methods where both have errors, which is standard in lab testing.
